WE FIGURED OUT WHEN THE MAGA CROWD THOUGHT AMERICA WAS

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks dw #40121
207
WE FIGURED OUT WHEN THE MAGA CROWD THOUGHT AMERICA WAS GREAT

By Jennifer Rubin
June 19, 2020

Quote:
It seems the leader of the MAGA crowd would be most at home when the Confederacy was still revered (by racists who promulgated the “Lost Cause” nonsense), when scientists lacked the ability to contradict him and when only certain kinds of voters (his) could manage to cast their ballots. For the rest of us who live in a modern, multiracial, technologically sophisticated 21st-century America, he seems like a poor fit for president.


I have always wondered when the MAGA crowd and its Great Leader thought America was great. We know their appeal to disgruntled white voters is an exercise in phony nostalgia and wish fulfillment. Implicit in their slogan is a desire to go back to a time when whites — white men, to be specific — were numerically, politically, economically and culturally unchallenged. But when was this, exactly? 1950? 1920? We might have to go back to the 19th century.

We got a hint this week when President Trump restated his support for U.S. Army bases to retain names of Confederate traitors and white supremacists. He said in one of his more bizarre interviews that removing the names would “divide” Americans. (We aren’t divided now, I suppose, because “America” to him is his white base.) We wouldn’t want to “bring people apart,” he insisted — as the traitors did when they took up arms against fellow Americans?

In the same interview, he said that no one really knew about Juneteenth (meaning, he and his lily-white staff were ignorant of it) until he brought it up. He also argued that his “when the looting starts, the shooting starts” comment was appropriate. Meanwhile, Republicans in the Senate blocked an effort to remove Confederate statues from the Capitol. I am getting the sense that Trump and his followers look back favorably on the Confederacy, the memory of which swells them with pride. (Does Trump know that, in addition to being racists and traitors, they were losers?)

If you want some really antiquated thinking, travel back before germ theory caught on in the 19th century. Since then, it has held us in good stead as we have eliminated many deadly diseases. In the current crisis, every health expert tells us that mask-wearing and social isolation save lives since the disease spreads by aerosols (tiny droplets in the air). Blocking that means of transmission can drive the infection rate down. We can test who still has the virus, trace others a person testing positive has come into contact with and then isolate those people. Pretty basic, right?

Nah, the science-denier in chief says testing is “overrated.” (Don’t people in the White House get tested regularly so they don’t infect him?) Masks are for suckers, or, in Trump’s mind, simply show you disapprove of him. The notion that people would follow medical advice and try to prevent becoming infected or infecting others seems foreign to him.

Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, observed in a podcast on Thursday that stay-at-home orders potentially saved millions of lives. Other studies have shown that if 80 percent of us wear masks, the rate of infection would plunge. Trump insists, with no evidence, that masks don’t help: “They put their finger on the mask, and they take them off, and then they start touching their eyes and touching their nose and their mouth. And then they don’t know how they caught it?” (If you take the mask off properly, by the strings around your ears, as small children can manage to do, it’s not an issue.)

“One of the problems we face in the United States is that unfortunately, there is a combination of an anti-science bias that people are — for reasons that sometimes are, you know, inconceivable and not understandable — they just don’t believe science and they don’t believe authority,” Fauci said.

That would include the president, who leads the anti-science brigade, although Fauci didn’t mention him specifically. Fauci continued, "It’s amazing sometimes the denial there is. It’s the same thing that gets people who are anti-vaxxers, who don’t want people to get vaccinated, even though the data clearly indicate the safety of vaccines.” Fauci added. “That’s really a problem.” Yes, it really is.

Trump cares about none of that science stuff. He’s ready to pack thousands into a closed arena in Tulsa. (Would Fauci attend such an event? “Personally, I would not. Of course not," he said.)

It seems the leader of the MAGA crowd would be most at home when the Confederacy was still revered (by racists who promulgated the “Lost Cause” nonsense), when scientists lacked the ability to contradict him and when only certain kinds of voters (his) could manage to cast their ballots. For the rest of us who live in a modern, multiracial, technologically sophisticated 21st-century America, he seems like a poor fit for president.

-washingtonpost.com
https://www.washingtonpost.com/opinions/2020/...was-great/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AB SKF to Hold EGM, Spin Off Automotive Assets

Updated Category News Views 5

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 1

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading
CABP Market Sees Potential in New Treatments Rising

Updated Category News Views 2

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Wooree Group Pushes for Rigorous Liposome Standards

Updated Category News Views 1

Rallying for Rigorous Scientific Validation Ever find yourself pondering how many so-called 'innovative' health products really deliver what they promise? Let me tell ya, Wooree Group’s CEO, Ji-yong Yoon, ain’t buying into flimsy claims. At the Vitafoods Asia 2026 event in Bangkok, Yoon sent a clear message: Without scientific validation, calling a product 'liposomal'...

Continue Reading
Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 2

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
SKF's Automotive Arm Set for Stockholm Debut in Dec

Updated Category News Views 4

The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...

Continue Reading
Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Updated Category News Views 2

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading

Top 5 Most Recently Viewed Articles

Joey Bosa's $12.6M Deal and His Future Beyond the NFL

Updated Category News Views 484

Joey Bosa: A Star on the Field and in Business Joey Bosa is making headlines not just for his performance on the football field but also for his impressive off-field ventures. With the announcement of a new contract, he is poised for a thrilling season ahead. A New Chapter with the Buffalo Bills Recently, Bosa secured a lucrative one-year deal valued at $12.6 million with...

Continue Reading
Tesla's Vision for the Future of Autonomous Transportation

Updated Category News Views 259

The Exciting Future of Tesla's Autonomous Vehicles The recent unveiling by Tesla has stirred excitement and curiosity among both fans and investors. At a vibrant event, Elon Musk showcased Tesla's ambitious vision for the future of transportation with the introduction of their long-anticipated driverless robotaxis. This presentation had every characteristic of Musk's...

Continue Reading
Ask Hercules: New Tool Boosts AI Visibility for SMBs

Updated Category News Views 19

AI Visibility: The New Frontier for SMBs There's a new name in town aiming to make sure small and midsize businesses aren't left in the dust of the AI revolution. Muse Platforms just launched Ask Hercules, an AI visibility platform that gives businesses, creators, and thought leaders a chance to assess and improve how they show up on AI platforms like ChatGPT, Claude, and...

Continue Reading
Transforming $100 into $343: A Look at ServiceNow's Growth

Updated Category News Views 68

How a $100 Investment in ServiceNow Could Transform Your Finances ServiceNow (NYSE: NOW) has shown remarkable performance in the stock market over the past five years, demonstrating an annualized return of 27.51%. Impressively, this places its overall growth at 13.52% above market averages. The Current Market Capitalization As it stands, ServiceNow boasts a substantial...

Continue Reading
Gladstone Land Faces Market Challenges as Stock Reaches Low

Updated Category News Views 426

Market Challenges for Gladstone Land Corporation In a rapidly evolving economic landscape, Gladstone Land Corporation (NASDAQ: LAND) has recently encountered hurdles as its stock dipped to a 52-week low, reaching a price of $10.44. This decline highlights the stock's turbulent journey over the past year, where it has decreased by approximately 27.82%. With a market...

Continue Reading